ACCESS

GASTROSTOMY

Introduction

Last updated: nov 22, 2024

Enteral tube feeding plays a crucial role in providing nutritional support to patients with intact digestive function who are unable to meet their nutritional needs through oral intake alone. Gastrostomy feeding is a well-established method for long-term enteral nutrition when oral feeding is either not feasible or considered unsafe.

Carotid artery

 

Anatomy

  • Previous surgery (e.g., abdominal hernia mesh repair).
  • Large hiatus hernia and superior stomach position in the thorax.
  • Posterior location of the stomach and/or long access tract in obese patients can be a risk factor for tube dislodgement and risk of intraperitoneal feeding and peritonitis.
  • Colonic interposition or distention can increase the risk of bowel puncture.
  • Large left lobe of liver anterior to the stomach.
  • Cachexia: higher risk of double puncture of the anterior and posterior stomach wall and injury to posterior structures.
  • Typically, gastric access is achieved in the left upper quadrant preferably at least one or two centimetres below the lowest palpable rib. This location decreases the risk of RIG tube irritating subcostal nerves and is better tolerated by the patients.
  • Anatomical constraints can preclude some RIG insertion techniques and CT guidance can be considered for these cases.

File NameTypePermissionsChanged DateDateSize

 

Indications

  • Inability to take adequate nutrients orally for more than four weeks.
  • Common conditions requiring a gastrostomy feeding tube include: neurological disorders e.g., motor neurone disease, dysphagia post cerebrovascular accident or acquired brain injury, cerebral palsy, slow recovering vegetative state.
  • Chronic pulmonary disease e.g., cystic fibrosis.
  • Upper GIT cancers e.g., head and neck, oesophageal .
  • Failure to thrive (paediatrics).
  • Metabolic disorders.
  • Chronic small-bowel obstruction requiring decompression gastrostomy.

 

Contra indications

Absolute

  • Non-functioning i.e., ileus, bowel ischaemia.
  • Incurable disease in terminal phase (prognosis
  • Advanced dementia.
  • Anorexia nervosa.
  • Severe ascites.
  • Extensive tumour infiltration of stomach.
  • Uncorrectable coagulation disorder.
  • Inability of patient/carer to comply with required care including appropriate home environment.
  • Life expectancy <30 days.

Relative

 

Pre procedural

  • Review of previous surgical treatments.
  • Always assess previous CT scan, in order to plan for the procedure.
  • Review of the CT of the abdomen to assess left liver lobe anatomy, colon position, large vessels or large hiatus hernia presence. Decision can be made at this point if to proceed with fluoroscopic insertion or with CT or dyna CT guidance. In case of significant bowel distention and antero-gastric position of the colon, flatus tube can be considered in the morning on the day of the procedure.
  • Antibiotic prophylaxis

 

Materials

Essentials

  • Ultrasound
  • Sterile drapes
  • 1% lidocaine
  • Sterile water
  • Gastrostomy set

Non-Essentials

 

Positioning the patient

  • Supine

 

The procedure in steps

  • Time out
  • Positioning patient
  • Sterile wash and drapes
  • Ultrasound guided punction
  • Mark the left liver edge, costal margin and inferior epigastric artery using US. This can be also done after air inflation of the stomach.
  • Prepare left subcostal area and epigastrium in sterile technique.
  • Prepare local anaesthetic, e.g. 1% lidocaine mixed with longer lasting local anesthetic (for example 1% xylocaine or 2.5 mg/ml bupivacaine)
  • It is reported that antibiotic prophylaxis may reduce the risk of infection, especially in the population of patients with head and neck cancers (e.g. Co-Amoxicillin 1.2g iv, or in case penicillin allergy teicoplanin can be considered). Antibiotic prophylaxis, in line with local protocols, is recommended)
  • Consider iv 20 mg Buscopan or Glucagon 0.5 to 1.0 mg IV to reduce gastric peristalsis.
  • Check nasogastric tube and colon position under fluoroscopy or ultrasound scan.
  • Insufflate the stomach with air through the nasogastric tube. Usually, 500 to 1000 mL of air is required to distend the stomach (air can be also gradually topped up, during the procedure).
  • Screen in AP position to mark the puncture sites towards the air in the distal body of the stomach using small anesthetic needles.
  • Avoid colon and liver margin.
  • Place 3 local anaesthetic needles advanced up to the stomach wall in a shape of a triangle, around the target position.
  • Technique with t-fasteners (gastropexy) is recommended:
    • alternate between AP and lateral views to perform gastropexy needle puncture,
    • perform 4 gastropexy punctures (3-2 if there is limited access space) on lateral view fluoroscopy. To demonstrate intragastric position aspirate the air, and follow with contrast injection through the needle
    • secure the gastropexy with "not too loose not too tight technique " at the skin.
  • Top up air if needed prior to 18-gauge angio needle puncture. Make a 0.5-1 cm incision on the skin preferentially in longitudinal plane to minimize transecting the inferior epigastric artery. Dissect the skin incision with blunt-nosed hemostat and proceed with the gastric puncture on lateral view fluoroscopy. Aspirate the air and inject contrast to demonstrate intragastric position. If jejunal tube is planned, the puncture should be performed towards the pylorus. Advance stiff wire through the angio needle.
  • Advance telescopic peel-away sheath over the stiff wire. It is crucial to make sure that the tract and thick gastric wall is dilating and not pushed away from the anterior abdominal wall. At this point, the wire can be dislodged from the stomach. Usually, gastropexies are helpful to prevent from this.
  • While removing the peel-away sheath dilator you can ask the assistant to inject small amount of sterile gel into the sheath to avoid fast gastric decompression and to prevent gastric content to irritate the skin.
  • Introduce the gastrostomy tube over the wire. It is easier to advance the tube, if it is preloaded with sterile lubricant gel.
  • Peel away half way the sheath and fill the balloon with sterile water for injection.
  • Make sure that maximal water volume is in the balloon, to avoid balloon losing its shape and sliding into a newly formed tract.
  • Complete peeling away the sheath and pull the tube immediately, until the balloon is against the anterior abdominal wall, securing the tract.
  • Inject contrast through the RIG to outline the gastric rugal folds and demonstrate the final tube position.
  • It is recommended to avoid skin suture, to avoid suture infection.
  • Document the volume of water in the balloon, tube length at the skin site and number of gastropexies used. This will help ward staff to assess the tube later and note any signs of tube dislodgment .
  • Minimal dressing should be applied to avoid soaking with gastric content and to prevent from irritation of the skin and the tract.

Bumper

  • If bigger caliber tube or more robust fixation in the stomach is required, bumper PEG tube can be placed using fluoroscopic, rendez-vous technique under general anaesthetic.
  • After stomach insufflation with air, percutaneous stomach puncture is performed towards the stomach fundus.
  • Wire is advanced through the needle and the needle is removed.
  • Wire is directed by catheter retrogradely, into the esophagus and out, through the mouth, for through-and¬through access
  • If the esophageal cannulation is challenging; primarily, loop snare can be advanced orally into the stomach lumen.
  • After stomach insufflation with air, percutaneous, 18-gauge needle puncture can be performed directing the needle through the open snare (25 mm loop snare or above),
  • The 260 cm stiff wire is advanced through the needle and the needle is removed,
  • The wire is snared to come out through the mouth, for a through-and-through access.
  • The gastric tract is dilated percutaneously to accommodate the tube size. Long sheath (60-90 cm) is used to maintain through-and-through access (above 9F), introduced from the stomach side.
  • Wire is removed.
  • Snare is now advanced from the percutaneous stomach puncture (through the sheath) to come out through the mouth.
  • Small loop suture at the external end of the PEG tube is attached to the snare from the mouth side. The PEG tube is now pulled against the sheath and together with the sheath pulled from the stomach side into the mouth, esophagus, stomach and out- through the skin leaving the disk in the stomach. Support is needed from the mouth to push the disk into the mouth and throat.
  • The tube is cut to fit.
  • No gastropexies are required with this technique.

 

Tips and tricks

  • If it is difficult to appreciate the inflated balloon under fluoroscopy, water for injection can be mixed with 1 ml of contrast to better opacify the balloon. The balloon should not be however inflated with more dense contrast solution due to higher risk of balloon damage.
  • Primary button tube technique was introduced in some centers. This requires balloon tract measurement and 18F sheath tract dilatation [12].
  • Saline causes the erosion of the balloon and may be a reason for the balloon to burst. Saline should not be used for balloon inflation.
  • The gastropexies should be at least 2 cm away from the balloon to avoid balloon damage.
  • If the patient feels significant discomfort due to one of the gastropexies being too tight or showing signs of infection, the gastropexy can be cut, allowing the other gastropexies are in place.
  • Due to some of the gastropexies being secured with absorbable suture, it is infrequent for the gastropexy to fell off prematurely. This can be expected especially if bleeding and hematoma occur. When non-absorbable sutures are used, it is advised to remove them after 10-14 days, when the tract is established.
  • The tract usually forms in 10-14 days and it is advised not to deflate the balloon earlier (maturation 4-6 weeks).
  • Two experienced practitioners should perform complex cases.
  • If telescopic dilator is unavailable, the tract can be subsequently dilated up to F larger, compared to the tube size. Dilatation with a balloon can be also considered.
  • If esophageal access is impossible stomach can be insufflated directly via CT or US guided 21G needle puncture.
  • In case direct jejunostomy is indicated, due to inaccessible stomach or after gastrectomy, surgical procedure using a Witzel tunnel or percutaneous jejunostomy can be considered. Mobility of the small intestine, small intestine's compliance, difficult distension and close proximity of the vital structures should be taken into consideration for percutaneous insertion
  • To exclude bowel perforation, x-ray is not recommended due to pneumoperitoneum being common finding after the procedure.

 

Complications

  • Superficial peristomal infection 25-45%
  • Leakage 11.4%
  • Tube occlusion 4.5%
  • Tube dislodgement 1.3-4.5%
  • Hemorrhage 1.4%
  • Peritonitis 1.3%
  • Death 0.3%
  • Colonic perforation rare
  • Severe skin infection rare

Accidental removal
One of the major problems associated with RIGs is accidental removal or partial withdrawal, often associated with balloon failure. It is important to establish a pathway for patients who have undergone RIG insertion to be able to access IR (preferably directly and without needing to attend the accident and emergency department) for RIG re-insertion, ideally within 24 hours. This is a simple procedure that can be performed with a 4F dilator and standard angled Terumo needle (exchanging for a short Amplatz wire and dilators once access to the stomach is confirmed fluoroscopically). In this way, it is possible to reinsert a RIG up to ten to fourteen days after the tube has fallen out even without a tube (e.g., Foley catheter) being placed in the tract to maintain overt patency. In the case of complete tract closure at the skin, the opening of the tract at the skin can sometimes be re-established with superficial instrumentation. The risks of reinsertion (including failure) increase the longer the tube has been out. Reinsertion should be performed with great care and by experienced operators in the case of an immature tract.

Tube blockage and damage
Enteral feeding tubes are prone to blockage, especially if they are used to administer crushed medications. They also can become damaged and split apart. Proteins in polymeric enteral feeds can precipitate and lead to tube blockage. Regular flushing with sterile water reduces the risk of blockage. Pancreatic enzymes +8.4% sodium bicarbonate can reduce tube occlusion 10-fold.

Other tube-related complications
Enteral feeding tubes can cause tissue erosion and ulceration anywhere along the insertion route and also hypergranulation, most commonly at the skin. Colonization of enteral tubes is common but clinically significant infection with an established tube and tract is rare. Hypergranulation can be treated in a number of ways including using silver nitrate.

Aspiration
Large feed volumes in the stomach may lead to reflux. The risk is higher with neurological deficit, some types of feed, feeding position, and high rates. Feeding beyond the ligament of Trietz reduces this (postpyloric feeding into the proximal duodenum can still result in significant oesophageal reflux).

Gastrointestinal symptoms
• Refeeding syndrome and other causes of electrolyte disturbances
• Hyperglycaemia
• Bloating and nausea
• Altered bowel habit (diarrhoea most commonly)
• Infection

Haemorrhage
RIG and PEG are less invasive with lower complication rates than surgical gastrostomy. Broadly speaking, the incidence of major complications after RIG or PEG ranges from 1-6%.
Upper gastrointestinal (GI) bleeding complicating gastrostomy is rare, but may be catastrophic when it occurs.
Most patients who experience gastric bleeding have undergone surgical gastrostomy or PEG, it is much less commonly reported in RIG.
The most common significant bleeding during RIG insertion is related to venous or arterial disruption of the inferior epigastric vessels. This can be minimized by making very superficial skin incisions. In our institution, it is convention to make the incision for the gastrostomy tube (superficially within the skin layer only) in a cranio-caudal orientation to minimize the risk of injuring the epigastric vessels. If there is significant bleeding at the gastrostomy site this can sometimes be managed by manual compression over an extended period (minor venous bleeding) but sometimes an inferior epigastric embolization artery is required.

Infection
The European Society of Gastrointestinal Endoscopy (ESGE) recommends the intravenous administration of a prophylactic single dose of a beta-lactam antibiotic (or alternative in allergy as per local antibiotic guidelines – clindamycin at our centre unless there is MRSA when Teicoplanin added to Clindamycin) to decrease risk of post-procedural wound infection (a strong ESGE recommendation with moderate quality evidence). However local antibiotic guidelines should be followed.
ESGE recommends local antiseptic measures and daily dressing changes for minor wound infections (non-extending) and broad-spectrum antibiotics for more severe infections. (A strong ESGE recommendation with low-quality evidence).

Buried Bumper (PIG)
ESGE recommends daily tube mobilisation (pushing inward) along with a loose position of the external bumper (1-2 cm from the abdominal wall) to mitigate the risk of buried bumper syndrome. (A strong ESGE recommendation with low-quality evidence).

Peristomal leakage
ESGE recommends treating any underlying pre-disposing disease and local treatment with absorbing agents, stoma adhesive powder, and zinc oxide to reduce local skin irritation. (a weak ESGE recommendation with low quality evidence base.) For persistent leakage there are varying strategies including downsizing or upsizing the tube and re-siting.

Even in the best units, 30-day mortality is 6% with 10% morbidity secondary to the procedure and underlying co-morbidities. Higher figures of 28% for in-patients and a median survival of 305 days have been published

  • The risk factors for 30-day mortality include
  • higher age
  • lower body mass index
  • C-reactive protein >21.5 g/L
  • diabetes mellitus
  • albumin <30 g/L
  • radiotherapy
  • cirrhosis
  • cancer
  • chronic obstructive pulmonary disease
  • residing in a nursing home

 

Post-op

Very low threshold for checking CT abdomen in patients that have significant post procedure pain.

 

Follow-up

Indications for replacing gastrostomy tubes

  • Tube dislodged including balloon failure.
  • Tube not functioning adequately: leaking, blocking regularly, blocked, and unable to restore patency.
  • Tube showing signs of significant deterioration: cracked, flattened, discoloured, split.
  • Tube is causing stoma site complications i.e., skin level device too tight causing pressure necrosis.
  • Patient factors: replacement with a skin level device for aesthetic reasons in paediatrics, growth in children with a skin level device becoming too tight.

Contraindications for replacing gastrostomy tubes

  • Immature stoma (less than 30 days).
  • If enteral nutrition is anticipated to be needed for >four weeks, percutaneous access should be considered rather than natural orifice (either nostril). The gastric route is the primary option - only in patients with altered/unfavourable gastric anatomy (e.g., after previous surgery), impaired gastric emptying, intolerance to gastric feeding, or with high aspiration risk should the jejunal route be chosen.
  • Recent gastrointestinal bleeding should be considered to be a relative contraindication to percutaneous enteral access procedures along with hemodynamic/respiratory instability.
  • Ascites and ventriculoperitoneal shunts are additional risk factors for infection requiring further preventive precautions.

 

Report

 

Patient folder

File NameTypePermissionsChanged DateDateSize

 

Literature

File NameTypePermissionsChanged DateDateSize

  1. J. Mark Ryan, MD, S. M. Key, Siobhan A. Dumbleton, MD, and Tony P. Smith, MD Nonlocalized Lower Gastrointestinal Bleeding: Provocative Bleeding Studies with Intraarterial tPA, Heparin, and Tolazoline J Vasc Interv Radiol 2001 Nov;12(11):1273-7

  2. Baum ST. Arteriographic diagnosis and treatment of gastrointestinal bleeding. In Baum ST, Pentecost MJ, eds. Abrams' angiography interventional radiology. 2nd ed. Philadelphia, Pa:Lippincott, Williams & Wilkins, 2006:488.

  3. Poultsides GA, Kim CJ, Orlando R 3rd, et al. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg. 2008;143:457-461.

  4. Eriksson LG, Sundbom M, Gustavsson S, Nyman R. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006;17:959-964.

  5. Dixon S, Chan V, Shrivastava V et al. Is there a role for empiric gastroduodenal artery embolization in the management of patients with active upper GI hemorrhage? Cardiovasc Intervent Radiol. 2013 Aug;36(4):970-7.

  6. Shin JH. Recent update of embolization of upper gastrointestinal tract bleeding. Korean J Radiol 2012;13 Suppl 1:S31-S39.

  7. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-24.

  8. Sildiroglu O, Muasher J, Arslan B, Sabri SS, Saad WE, Angle JF, Matsumoto AH, Turba UC. Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy. J Clin Gastroenterol. 2014;48(8):687-92.

  9. Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Apr;111(4):459-74.

  10. van Dam J, Brugge WR. Endoscopy of the upper gastrointestinal tract. N Engl J Med. 1999;341(23):1738-48.

  11. Lefkovitz Z, Cappell MS, Lookstein R, Mitty HA, Gerard PS. Radiologic diagnosis and treatment of gastrointestinal hemorrhage and ischemia. Med Clin North Am. 2002 Nov;86(6):1357-99.

  12. Lee EW, Laberge JM. Differential diagnosis of gastrointestinal bleeding. Tech Vasc Interv Radiol 2004; 7: 112-22

  13. Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Apr;111(4):459-74.

  14. Chaudhry V, Hyser MJ, Gracias VH, Gau FC. Colonoscopy: the initial test for acute lower gastrointestinal bleeding. Am Surg. 1998 Aug;64(8):723-8.

  15. Cummings CL. Value of early capsular endoscopy for severe gastrointestinal bleeding. J Natl Med Assoc. 2004;96(12):1653-6.

  16. Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent small-bowel bleeding. N Engl J Med. 2001;344(3):232-3.

  17. Lim JK, Ahmed A. Endoscopic approach to the treatment of gastrointestinal bleeding. Tech Vasc Interv Radiol. 2004 Sep;7(3):123-9.

  18. Nicholson AA, Ettles DF, Hartley JE, et al. Transcatheter coil embolotherapy: a safe and effective option for major colonic haemorrhage. Gut 1998; 43:79–84.

  19. Zuckier LS. Acute gastrointestinal bleeding. Semin Nucl Med. 2003 Oct;33(4):297-311.

  20. Imbembo AL, Diverticular disease of the colon. In: Sabiston D, Editor. Textbook of Surgery (14th edn). Philadelphia, PA:WB Saunders, 1992:910.

  21. Loffroy R, Rao P, Ota S, De Lin M, Kwak BK, Geschwind JF. Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol. 2010 Dec;33(6):1088-100. doi: 10.1007/s00270-010-9829-7. Epub 2010 Mar 16.

  22. Eriksson LG, Sundbom M, Gustavsson S, Nyman R. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006 Jun;17(6):959-64.

  23. Anthony S, Milburn S, Uberoi R. Multi-detector CT: review of its use in acute GI haemorrhage. Clin Radiol. 2007 Oct;62(10):938-49.

  24. Ernst O, Bulois P, Saint-Drenant S, Leroy C, Paris JC, Sergent G. Helical CT in acute lower gastrointestinal bleeding. Eur Radiol. 2003;13(1):114-7

  25. Mirsadraee S, Tirukonda P, Nicholson A, Everett SM, McPherson SJ. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011;66:500-509.

  26. Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krausé D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009 May;7(5):515-23.

  27. Aina R, Oliva VL, Therasse E, et al. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001;12:195-200.

  28. Mirsadraee S, Tirukonda P, Nicholson A, Everett SM, McPherson SJ. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011;66:500-509.

  29. Loffroy R, Guiu B, Cercueil JP, Lepage C, Latournerie M, Hillon P, Rat P, Ricolfi F, Krausé D. Refractory bleeding from gastroduodenal ulcers: arterial embolization in high-operative-risk patients. J Clin Gastroenterol. 2008 Apr;42(4):361-7.

  30. Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krausé D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009 May;7(5):515-23.

  31. Poultsides GA, Kim CJ, Orlando R 3rd, Peros G, Hallisey MJ, Vignati PV. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg 2008;143:457-461.

  32. Gordon RL, Ahl KL, Kerlan RK, Wilson MW, LaBerge JM, Sandhu JS, Ring EJ, Welton ML. Selective arterial embolization for the control of lower gastrointestinal bleeding. Am J Surg. 1997;174(1):24-8.

  33. Funaki B, Kostelic JK, Lorenz J, Ha TV, Yip DL, Rosenblum JD, et al. Superselective microcoil embolization of colonic hemorrhage. AJR Am J Roentgenol 2001;177:829-836 7.

  34. Bandi R, Shetty PC, Sharma RP, Burke TH, Burke MW, Kastan D. Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2001;12:1399-1405.

  35. Maleux G, Roeflaer F, Heye S, Vandersmissen J, Vliegen AS, Demedts I, et al. Long-term outcome of transcatheter embolotherapy for acute lower gastrointestinal hemorrhage. Am J Gastroenterol 2009;104:2042-2046

  36. Leitman IM, Paull DE, Shires GT 3rd. Evaluation and management of massive lower gastrointestinal hemorrhage. Ann Surg 1989;209:175-180

  37. Rosenkrantz H, Bookstein JJ, Rosen RJ, Goff WB 2nd, Healy JF. Postembolic colonic infarction. Radiology 1982;142:47-51.

  38. Koh DC, Luchtefeld MA, Kim DG, Knox MF, Fedeson BC, Vanerp JS, et al. Efficacy of transarterial embolization as definitive treatment in lower gastrointestinal bleeding. Colorectal Dis 2009;11:53-59

  39. Lipof T, Sardella WV, Bartus CM, Johnson KH, Vignati PV, Cohen JL. The efficacy and durability of super-selective embolization in the treatment of lower gastrointestinal bleeding. Dis Colon Rectum 2008;51:301-305

  1. Lee EW, Laberge JM. Differential diagnosis of gastrointestinal bleeding. Tech Vasc Interv Radiol 2004; 7: 112-22

  2. Baum ST. Arteriographic diagnosis and treatment of gastrointestinal bleeding. In Baum ST, Pentecost MJ, eds. Abrams' angiography interventional radiology. 2nd ed. Philadelphia, Pa:Lippincott, Williams & Wilkins, 2006:488.

  3. Poultsides GA, Kim CJ, Orlando R 3rd, et al. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg. 2008;143:457-461.

  4. Eriksson LG, Sundbom M, Gustavsson S, Nyman R. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006;17:959-964.

  5. Dixon S, Chan V, Shrivastava V et al. Is there a role for empiric gastroduodenal artery embolization in the management of patients with active upper GI hemorrhage? Cardiovasc Intervent Radiol. 2013 Aug;36(4):970-7.

  6. Shin JH. Recent update of embolization of upper gastrointestinal tract bleeding. Korean J Radiol 2012;13 Suppl 1:S31-S39.

  7. van Leerdam ME. Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol. 2008;22(2):209-24.

  8. Sildiroglu O, Muasher J, Arslan B, Sabri SS, Saad WE, Angle JF, Matsumoto AH, Turba UC. Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy. J Clin Gastroenterol. 2014;48(8):687-92.

  9. Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Apr;111(4):459-74.

  10. van Dam J, Brugge WR. Endoscopy of the upper gastrointestinal tract. N Engl J Med. 1999;341(23):1738-48.

  11. Lefkovitz Z, Cappell MS, Lookstein R, Mitty HA, Gerard PS. Radiologic diagnosis and treatment of gastrointestinal hemorrhage and ischemia. Med Clin North Am. 2002 Nov;86(6):1357-99.

  12. Lee EW, Laberge JM. Differential diagnosis of gastrointestinal bleeding. Tech Vasc Interv Radiol 2004; 7: 112-22

  13. Strate LL, Gralnek IM. ACG Clinical Guideline: Management of Patients With Acute Lower Gastrointestinal Bleeding. Am J Gastroenterol. 2016 Apr;111(4):459-74.

  14. Chaudhry V, Hyser MJ, Gracias VH, Gau FC. Colonoscopy: the initial test for acute lower gastrointestinal bleeding. Am Surg. 1998 Aug;64(8):723-8.

  15. Cummings CL. Value of early capsular endoscopy for severe gastrointestinal bleeding. J Natl Med Assoc. 2004;96(12):1653-6.

  16. Appleyard M, Glukhovsky A, Swain P. Wireless-capsule diagnostic endoscopy for recurrent small-bowel bleeding. N Engl J Med. 2001;344(3):232-3.

  17. Lim JK, Ahmed A. Endoscopic approach to the treatment of gastrointestinal bleeding. Tech Vasc Interv Radiol. 2004 Sep;7(3):123-9.

  18. Nicholson AA, Ettles DF, Hartley JE, et al. Transcatheter coil embolotherapy: a safe and effective option for major colonic haemorrhage. Gut 1998; 43:79–84.

  19. Zuckier LS. Acute gastrointestinal bleeding. Semin Nucl Med. 2003 Oct;33(4):297-311.

  20. Imbembo AL, Diverticular disease of the colon. In: Sabiston D, Editor. Textbook of Surgery (14th edn). Philadelphia, PA:WB Saunders, 1992:910.

  21. Loffroy R, Rao P, Ota S, De Lin M, Kwak BK, Geschwind JF. Embolization of acute nonvariceal upper gastrointestinal hemorrhage resistant to endoscopic treatment: results and predictors of recurrent bleeding. Cardiovasc Intervent Radiol. 2010 Dec;33(6):1088-100. doi: 10.1007/s00270-010-9829-7. Epub 2010 Mar 16.

  22. Eriksson LG, Sundbom M, Gustavsson S, Nyman R. Endoscopic marking with a metallic clip facilitates transcatheter arterial embolization in upper peptic ulcer bleeding. J Vasc Interv Radiol. 2006 Jun;17(6):959-64.

  23. Anthony S, Milburn S, Uberoi R. Multi-detector CT: review of its use in acute GI haemorrhage. Clin Radiol. 2007 Oct;62(10):938-49.

  24. Ernst O, Bulois P, Saint-Drenant S, Leroy C, Paris JC, Sergent G. Helical CT in acute lower gastrointestinal bleeding. Eur Radiol. 2003;13(1):114-7

  25. Mirsadraee S, Tirukonda P, Nicholson A, Everett SM, McPherson SJ. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011;66:500-509.

  26. Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krausé D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009 May;7(5):515-23.

  27. Aina R, Oliva VL, Therasse E, et al. Arterial embolotherapy for upper gastrointestinal hemorrhage: outcome assessment. J Vasc Interv Radiol 2001;12:195-200.

  28. Mirsadraee S, Tirukonda P, Nicholson A, Everett SM, McPherson SJ. Embolization for non-variceal upper gastrointestinal tract haemorrhage: a systematic review. Clin Radiol 2011;66:500-509.

  29. Loffroy R, Guiu B, Cercueil JP, Lepage C, Latournerie M, Hillon P, Rat P, Ricolfi F, Krausé D. Refractory bleeding from gastroduodenal ulcers: arterial embolization in high-operative-risk patients. J Clin Gastroenterol. 2008 Apr;42(4):361-7.

  30. Loffroy R, Guiu B, D'Athis P, Mezzetta L, Gagnaire A, Jouve JL, Ortega-Deballon P, Cheynel N, Cercueil JP, Krausé D. Arterial embolotherapy for endoscopically unmanageable acute gastroduodenal hemorrhage: predictors of early rebleeding. Clin Gastroenterol Hepatol. 2009 May;7(5):515-23.

  31. Poultsides GA, Kim CJ, Orlando R 3rd, Peros G, Hallisey MJ, Vignati PV. Angiographic embolization for gastroduodenal hemorrhage: safety, efficacy, and predictors of outcome. Arch Surg 2008;143:457-461.

  32. Gordon RL, Ahl KL, Kerlan RK, Wilson MW, LaBerge JM, Sandhu JS, Ring EJ, Welton ML. Selective arterial embolization for the control of lower gastrointestinal bleeding. Am J Surg. 1997;174(1):24-8.

  33. Funaki B, Kostelic JK, Lorenz J, Ha TV, Yip DL, Rosenblum JD, et al. Superselective microcoil embolization of colonic hemorrhage. AJR Am J Roentgenol 2001;177:829-836 7.

  34. Bandi R, Shetty PC, Sharma RP, Burke TH, Burke MW, Kastan D. Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol 2001;12:1399-1405.

  35. Maleux G, Roeflaer F, Heye S, Vandersmissen J, Vliegen AS, Demedts I, et al. Long-term outcome of transcatheter embolotherapy for acute lower gastrointestinal hemorrhage. Am J Gastroenterol 2009;104:2042-2046

  36. Leitman IM, Paull DE, Shires GT 3rd. Evaluation and management of massive lower gastrointestinal hemorrhage. Ann Surg 1989;209:175-180

  37. Rosenkrantz H, Bookstein JJ, Rosen RJ, Goff WB 2nd, Healy JF. Postembolic colonic infarction. Radiology 1982;142:47-51.

  38. Koh DC, Luchtefeld MA, Kim DG, Knox MF, Fedeson BC, Vanerp JS, et al. Efficacy of transarterial embolization as definitive treatment in lower gastrointestinal bleeding. Colorectal Dis 2009;11:53-59

  39. Lipof T, Sardella WV, Bartus CM, Johnson KH, Vignati PV, Cohen JL. The efficacy and durability of super-selective embolization in the treatment of lower gastrointestinal bleeding. Dis Colon Rectum 2008;51:301-305

DISCLAIMER

The information contained herein has been obtained from sources believed to be reliable. However, no warranty as to the accuracy, completeness or adequacy of such information is implied. No liability is accepted for errors, omissions or inadequacies in the information contained herein or for interpretations thereof. The reader assumes sole responsibility for the selection of these materials to achieve its intended results. The opinions expressed herein are subject to change without notice.

Thank you! ×
Opps! Some went wrong... Your submission did not go through :-(×
Stacks Image 14

WEBDESIGN

Stacks Image 20

PHOTOGRAPHY

Stacks Image 26

E-COMMERCE

Stacks Image 32

SEO

Stacks Image 38

COLORS

Stacks Image 44

CRM

EXCELLENCE IS NOT A SKILL, IT'S AN ATTITTUDE

WEBDESIGN - PHOTOGRAPHY - GRAVENDEEL